Table 7. | Demographic characteristics of the included studies |
| Study |
Year of publication |
Study design |
Patients (n) |
Age (years) |
Gender | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Test | Control | Test | Control | Test | Control | |||
| Mean (SD) | Mean (SD) | ||||||||
| De Angelis et al. [21] | 2020 | Prospective clinical trial | 34 | 17 | 17 | NR | NR | NR | NR |
| Cosyn et al. [22] | 2021 | Randomized controlled trial | 60 | 30 | 30 | 48.2 (16.3) | 50.1 (17) |
14 males 16 females |
15 males 15 females |
| Puisys et al. [23] | 2021 | Randomized controlled trial | 45 | 23 | 22 | 41.6 (7.66) | 39.8 (8.56) |
11 males 12 females |
9 males 13 females |
| Thoma et al. [24] | 2022 | Randomized controlled trial | 20 | 10 | 10 | 44.1 (12.8) | 43.4 (18.7) |
3 Males 7 females |
4 Males 6 females |
| De Angelis et al. [25] | 2023 | Prospective clinical trial | 48 | 24 | 24 | NR | NR |
13 males 11 females |
13 males 11 females |
| Ashurko et al. [26] | 2025 | Randomized controlled trial | 32 | 16 | 16 | 41.94 (9.62) | 37.19 (7.13) |
3 males 13 females |
6 males 10 females |
NR = not recorded. |
.png)
.png)
.png)
.png)
.png)
.png)
.png)